ArticleAnnals of the rheumatic diseases2021

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab.

Hendrik Schulze-Koops et al.PubMed ↗Publisher ↗

No numbers read from the abstract.